Axitinib: from preclinical development to future clinical perspectives in renal cell carcinoma
Overview of attention for article published in Expert Opinion on Drug Discovery, June 2015
Altmetric Badge
About this Attention Score
-
In the top 25% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (87th percentile)
-
High Attention Score compared to outputs of the same age and source (96th percentile)
Readers on
- mendeley
- 13 Mendeley